Current therapeutic strategies for HCV-associated cryoglobulinemia

Peripheral Ulcerative Keratitis Associated with HCV-Related Cryoglobulinemia

PURPOSE To describe a case of peripheral ulcerative keratitis associated with type II cryoglobulinemia in the context of Hepatitis C infection. METHODS Case report and literature review. RESULTS A 36-year-old male patient presented to our emergency department with unilateral moderate pain in his right eye, associated with redness and photophobia. Medical background elicited a history of Hep...

Hemangiomas - current therapeutic strategies.

Hemangiomas are benign neoplasms of the vasculature frequently encountered in children. Several studies have shown that these tumors are characterized by excessive angiogenesis. Although benign, the lesions can present with complications, and may thus require treatment. There are multiple therapeutic options available for patients with problematic or life threatening hemangiomas, some of which ...

HCV, Mixed Cryoglobulinemia and Malignant Lymphoproliferation

Current Therapeutic Strategies for Human Usher Syndrome

The human Usher syndrome (USH) is the most frequent cause of combined deafblindness in man. It is clinically and genetically heterogeneous and at least twelve chromosomal loci are assigned to three clinical USH types. USH1, USH2 and USH3 differ in the severity of the symptoms: hearing loss, balance problems and retinal degeneration namely retinitis pigmentosa (RP), as well as in the progression...

Current therapeutic strategies in glomerulonephritis.

Over the past 20 years the therapy of glomerulonephritis (GN) has evolved. Today apart from steroids and cyclophosphamide, newer agents like cyclopsorine A and tracrolimus (FK 506) have been reported to achieve remission (partial or complete) in patients with nephrotic syndrome due to various GN which have failed to respond to steroids and cyclophosphamide. For those patients who do not respond...